Publications 2024

Ellingjord-Dale M, Brunvoll SH, Søraas A (2024)
Prospective Memory Assessment before and after Covid-19
N Engl J Med, 390 (9), 863-865
DOI 10.1056/NEJMc2311200, PubMed 38416436

Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
Epigenetic aging of human blood cells is influenced by the age of the host body
Aging Cell, e14112 (in press)
DOI 10.1111/acel.14112, PubMed 38439206

Søraas A, Brunvoll SH, Nygaard AB, Dahl JA, Ursin G (2024)
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan
Lancet, 403 (10434), 1336
DOI 10.1016/S0140-6736(24)00414-8, PubMed 38582558

Publications 2023

Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
Scand J Immunol, 98 (1), e13274
DOI 10.1111/sji.13274, PubMed 37676118

Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J (2023)
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
Cell Rep, 42 (1), 111995
DOI 10.1016/j.celrep.2023.111995, PubMed 36656713

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 8 (1), 4
DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Publications 2022

Brunvoll SH, Nygaard AB, Ellingjord-Dale M, Holland P, Istre MS, Kalleberg KT, Søraas CL, Holven KB, Ulven SM, Hjartåker A, Haider T, Lund-Johansen F, Dahl JA, Meyer HE, Søraas A (2022)
Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial
BMJ, 378, e071245
DOI 10.1136/bmj-2022-071245, PubMed 36215222

Brunvoll SH, Nygaard AB, Fagerland MW, Holland P, Ellingjord-Dale M, Dahl JA, Søraas A (2022)
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
Int J Infect Dis, 126, 10-13
DOI 10.1016/j.ijid.2022.11.009, PubMed 36375693

Ellingjord-Dale M, Kalleberg KT, Istre MS, Nygaard AB, Brunvoll SH, Eggesbø LM, Dahl JA, Kjetland EF, Ursin G, Søraas A (2022)
The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway
BMC Infect Dis, 22 (1), 252
DOI 10.1186/s12879-022-07233-5, PubMed 35287611

Gohli J, Anderson AM, Brantsaeter AB, Bøifot KO, Grub C, Hadley CL, Lind A, Pettersen ES, Søraas AVL, Dybwad M (2022)
Dispersion of SARS-CoV-2 in air surrounding COVID-19-infected individuals with mild symptoms
Indoor Air, 32 (2), e13001
DOI 10.1111/ina.13001, PubMed 35225394

Granerud BK, Ueland T, Lind A, Søraas A, Fevang B, Steffensen AK, Al-Baldawi H, Lund-Johansen F, Aukrust P, Halvorsen B, Dahl TB, Dudman S, Müller F, Holter JC (2022)
Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
Viruses, 14 (11)
DOI 10.3390/v14112420, PubMed 36366518

Hagen BI, Lerdal A, Søraas A, Landrø NI, Bø R, Småstuen MC, Becker J, Stubberud J (2022)
Cognitive rehabilitation in post-COVID-19 condition: A study protocol for a randomized controlled trial
Contemp Clin Trials, 122, 106955
DOI 10.1016/j.cct.2022.106955, PubMed 36208718

Hetland G, Fagerhol MK, Dimova-Svetoslavova VP, Mirlashari MR, Nguyen NT, Lind A, Kolset SO, Søraas AVL, Nissen-Meyer LSH (2022)
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donors
Scand J Clin Lab Invest, 82 (6), 481-485
DOI 10.1080/00365513.2022.2123387, PubMed 36151851

Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
Vaccines (Basel), 10 (8)
DOI 10.3390/vaccines10081267, PubMed 36016155

Holland P, Wildhagen M, Istre M, Reiakvam OM, Dahl JA, Søraas A (2022)
Cri du chat syndrome patients have DNA methylation changes in genes linked to symptoms of the disease
Clin Epigenetics, 14 (1), 128
DOI 10.1186/s13148-022-01350-3, PubMed 36242045

Lee Y, Riskedal E, Kalleberg KT, Istre M, Lind A, Lund-Johansen F, Reiakvam O, Søraas AVL, Harris JR, Dahl JA, Hadley CL, Jugessur A (2022)
EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection
Sci Rep, 12 (1), 11478
DOI 10.1038/s41598-022-15467-1, PubMed 35798818

Schultz NH, Søraas AVL, Sørvoll IH, Akkök ÇA, Vetlesen A, Bhamra JS, Ahlen MT, Holme PA, Aamodt AH, Skagen K, Skattør TH, Skjelland M, Wiedmann MK (2022)
Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
J Stroke Cerebrovasc Dis, 32 (1), 106860
DOI 10.1016/j.jstrokecerebrovasdis.2022.106860, PubMed 36403363

Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Front Immunol, 13, 964525
DOI 10.3389/fimmu.2022.964525, PubMed 36159859

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
NPJ Vaccines, 7 (1), 174
DOI 10.1038/s41541-022-00586-7, PubMed 36585405

Publications 2021

Blom KB, Åsberg A, Sjaastad I, Kalleberg KT, Søraas A, Midtvedt K, Birkeland JA (2021)
Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
Kidney Med, 4 (2), 100389
DOI 10.1016/j.xkme.2021.09.006, PubMed 34805967

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
J Neurol Neurosurg Psychiatry, 94 (1), 19-22
DOI 10.1136/jnnp-2021-327612, PubMed 34670844

Søraas A, Bø R, Kalleberg KT, Støer NC, Ellingjord-Dale M, Landrø NI (2021)
Self-reported Memory Problems 8 Months After COVID-19 Infection
JAMA Netw Open, 4 (7), e2118717
DOI 10.1001/jamanetworkopen.2021.18717, PubMed 34323987

Søraas A, Kalleberg KT, Dahl JA, Søraas CL, Myklebust TÅ, Axelsen E, Lind A, Bævre-Jensen R, Jørgensen SB, Istre MS, Kjetland EF, Ursin G (2021)
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
PLoS One, 16 (8), e0256142
DOI 10.1371/journal.pone.0256142, PubMed 34437579

Publications 2020

Gilmour BC, Gudmundsrud R, Frank J, Hov A, Lautrup S, Aman Y, Røsjø H, Brenner C, Ziegler M, Tysnes OB, Tzoulis C, Omland T, Søraas A, Holmøy T, Bergersen LH, Storm-Mathisen J, Nilsen H, Fang EF (2020)
Targeting NAD⁺ in translational research to relieve diseases and conditions of metabolic stress and ageing
Mech Ageing Dev, 186, 111208
DOI 10.1016/j.mad.2020.111208, PubMed 31953124

Matsuyama M, Søraas A, Yu S, Kim K, Stavrou EX, Caimi PF, Wald D, deLima M, Dahl JA, Horvath S, Matsuyama S (2020)
Analysis of epigenetic aging in vivo and in vitro: Factors controlling the speed and direction
Exp Biol Med (Maywood), 245 (17), 1543-1551
DOI 10.1177/1535370220947015, PubMed 32762265

Publications 2019

Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319

Publications 2018

Bollestad M, Grude N, Solhaug S, Raffelsberger N, Handal N, Nilsen HS, Romstad MR, Emmert A, Tveten Y, Søraas A, Jenum PA, Jenum S, Møller-Stray J, Weme ET, Lindbaek M, Simonsen GS, (the Norwegian ESBL UTI study group) (2018)
Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study
J Antimicrob Chemother, 73 (9), 2503-2509
DOI 10.1093/jac/dky230, PubMed 29982514

Publications 2017

Jørgensen SB, Søraas A, Arnesen LS, Leegaard T, Sundsfjord A, Jenum PA (2017)
First environmental sample containing plasmid-mediated colistin-resistant ESBL-producing Escherichia coli detected in Norway
APMIS, 125 (9), 822-825
DOI 10.1111/apm.12720, PubMed 28640456

Jørgensen SB, Søraas A, Sundsfjord A, Liestøl K, Leegaard TM, Jenum PA (2017)
Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection - A three year prospective cohort study
PLoS One, 12 (3), e0173510
DOI 10.1371/journal.pone.0173510, PubMed 28267783

Jørgensen SB, Søraas AV, Arnesen LS, Leegaard TM, Sundsfjord A, Jenum PA (2017)
A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location
PLoS One, 12 (10), e0186576
DOI 10.1371/journal.pone.0186576, PubMed 29040337

Publications 2015

Søraas AV (2015)
[ESBL – risk factors and treatment]
Tidsskr Nor Laegeforen, 135 (20), 1880
DOI 10.4045/tidsskr.15.0798, PubMed 26534823

Publications 2014

Søraas A, Olsen I, Sundsfjord A, Handal T, Bjørang O, Jenum PA (2014)
Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae
J Oral Microbiol, 6
DOI 10.3402/jom.v6.24026, PubMed 25206941

Søraas A, Sundsfjord A, Jørgensen SB, Liestøl K, Jenum PA (2014)
High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli
PLoS One, 9 (1), e85889
DOI 10.1371/journal.pone.0085889, PubMed 24454943

Publications 2013

Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA (2013)
Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country
PLoS One, 8 (7), e69581
DOI 10.1371/journal.pone.0069581, PubMed 23936052